Records containing: Myelodysplastic Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-04-21Transfer of Donor-Derived Humoral Immunity Following Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-04-16Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-03-05Allogeneic Stem Cell Transplantation With Alternative Donor in Treatment of Hematologic Malignancy
-
CLINICAL_TRIALS study record update · 2020-02-28Cord Blood Expansion on Mesenchymal Stem Cells
-
CLINICAL_TRIALS study record update · 2020-02-26A Phase 3, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-02-18Phase II Study of INCB018424 in Patients With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2020-02-11Natural Killer Cells in Allogeneic Cord Blood Transplantation
-
CLINICAL_TRIALS study record update · 2020-01-27Post-authorization, Observational Study to Assess the Evolution in the Normal Clinical Practise of Patients With Recent Diagnosis of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML), Depending on the Time of Active Treatment Initiated
-
CLINICAL_TRIALS study record update · 2020-01-23A Trial for Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2020-01-21CD-34 Selection for Ex-vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Receiving Intensive Conditioning
-
CLINICAL_TRIALS study record update · 2020-01-14Molecular Epidemiology of Treatment-Related Acute Myeloid Leukemia/Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2020-01-10Integrating a Telemonitoring Device Into the Outpatient Management of Adult Patients Following Intensive Chemotherapy for MDS and Non-APL AML: A Randomized Pilot Study
-
CLINICAL_TRIALS study record update · 2020-01-07A Pilot Phase II Study of Erlotinib for the Treatment of Patients With Refractory/Relapsed AML
-
CLINICAL_TRIALS study record update · 2019-12-17Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults
-
CLINICAL_TRIALS study record update · 2019-12-16Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
-
CLINICAL_TRIALS study record update · 2019-12-16Multi-Center Phase II Trial of NK Cell Based Non-Myeloablative Haploidentical Transplantation for Patients With High-Risk Acute Myeloid Diseases
-
CLINICAL_TRIALS study record update · 2019-12-13A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2019-12-12HLA-Matched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation Followed by T Cell Add-Back for Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2019-12-10Sequential Administration of 5-azacytidine (AZA) and Donor Lymphocyte Infusion (DLI) for Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) in Relapse After Allogeneic Stem Cell Transplantation.
-
CLINICAL_TRIALS study record update · 2019-11-25Phase II of Erlotinib an Epidermal Growth Factor Receptor Inhibitor in the Treatment of Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2019-11-19A Single-Arm, Open-Label Study of the Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Red Blood Cell Transfusion-Dependent Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2019-11-18VIDAZA® Drug Use Examination
-
CLINICAL_TRIALS study record update · 2019-11-18Observational, Non-interventional, Multicenter Study Aimed at Collecting Retrospective/Prospective 648/96 Italian Registry Data Related to Lenalidomide (Revlimid®) Prescription to Patients With Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2019-11-15Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2019-11-08A Phase II Open Label Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome